Pacific Shuanglin Bio-Pharmacy Co., Ltd. logo

Pacific Shuanglin Bio-Pharmacy Co., Ltd.

000403 · SZSE · China

slbiop.com

Financials as of FY2025

What stands out
  • Earnings significantly exceed cash generation
At a glance
  • Depends onUpstream position: supplies 6 industries, depends on 3
  • ScaleMarket cap is $1.27B, above the global median of $1.14B
  • PositionPrice-to-book is 1.06×, lower than 95% of its Biotechnology peers (median 4.38×)
  • Interpretations2 currently firing — 2